Back to Search
LLOYD DAMON, MD
MD
Medical Oncology Physician
NPI: 1548224058IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
G51715(CA)
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
G51715(CA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
G51715(CA)
Education
UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Class of 1982
Research & Publications (20)
Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma.
PMID 18679366·Bone Marrow Transplant·2008
3-trial
Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.
PMID 16503501·Biol Blood Marrow Transplant·2006
4-observational
Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule.
PMID 15138711·Cancer Chemother Pharmacol·2004
3-trial
High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in California.
PMID 11063378·Biol Blood Marrow Transplant·2000
4-observational
Auto-SCT for AML in second remission: CALGB study 9620.
PMID 19289999·Bone Marrow Transplant·2009
4-observational
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.
PMID 19636009·J Clin Oncol·2009
3-trial
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).
PMID 19556425·Blood·2009
3-trial
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.
PMID 19021050·Leuk Lymphoma·2008
3-trial
Protein biomarker identification in the CSF of patients with CNS lymphoma.
PMID 18056677·J Clin Oncol·2008
4-observational
Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.
PMID 17312328·J Clin Oncol·2007
3-trial
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology.
PMID 16507273·J Natl Compr Canc Netw·2006
6-review
Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
PMID 17102115·Ann N Y Acad Sci·2006
3-trial
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
PMID 17002625·Transfusion·2006
3-trial
Acute myeloid leukemia clinical practice guidelines in oncology.
PMID 16403402·J Natl Compr Canc Netw·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 PARNASSUS AVE
SAN FRANCISCO, CA 94143 - Phone
- (415) 353-2421
Quick Facts
- NPI
- 1548224058
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile